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Divergent Effects of Disease-Associated Mutations on Type 2 Ryanodine
Receptor Channel
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Type 2 ryanodine receptor (RyR2) is a Ca2þ release channel in the sarco-
plasmic reticulum and plays a pivotal role in excitation-contraction coupling
in heart. RyR2 is the major target for arrhythmogenic diseases, e.g., catechol-
aminergic polymorphic ventricular tachycardia (CPVT) and arrhythmogenic
right ventricular cardiomyopathy (ARVC). To date, over 150 mutations have
been identified in the RyR2 gene of CPVT and ARVC patients. It is widely
believed that CPVT and ARVC mutations cause hyperactivation of the
Ca2þ-induced Ca2þ release (CICR), resulting in abnormal Ca2þ homeostasis
in cardiac muscle. CICR shows biphasic Ca2þ dependence against cytoplasmic
Ca2þ, thus the activity can be determined by three parameters: sensitivity to
activating Ca2þ, sensitivity to inactivating Ca2þ, and the gain (i.e., peak
activity). In addition, CICR is also regulated by luminal Ca2þ; high luminal
Ca2þ activates CICR, and vise versa. However, it remains unclear how the
disease-associated mutations affect these parameters. In this study, we ex-
pressed RyR2 channels carrying several CPVT/ARVC mutations in HEK cells
and tested their CICR by live-cell Ca2þ imaging and [3H]ryanodine binding.
Our results suggest that the disease-associated mutations divergently affects
the parameters of CICR depending on the sites for mutation. The underlying
molecular mechanism will be discussed.
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Crystal Structure of Cardiac Ryanodine Receptor N-Terminal Region
Contains Unique Anion Binding Site Targeted by Disease-Associated
Mutations
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Ryanodine receptors (RyRs) are intracellular calcium-release channels of the
endo/sarcoplasmic reticulum that are critical to the muscle excitation-
contraction coupling. Mutations in the cardiac isoform (RyR2) are linked to
life-threatening arrhythmias, such as catecholaminergic polymorphic ventricu-
lar tachycardia (CPVT), known for a sudden cardiac arrest. RyR2 is the target
for over 150 disease-associated mutations. Here, we present the 2.0A˚ crystal
structure of the N-terminal region of RyR2 (residues 1-547), an area containing
29 distinct disease-associated mutations. The protein folds up in three individ-
ual domains similarly to its counterpart in the skeletal muscle, RyR1, but con-
tains a unique central chloride anion that holds together the three domains. The
CPVT-associated mutant R420Q targets one of the Arginines coordinating the
anion and ablates chloride binding. The crystal structure of the mutant shows
reorientations in the first two domains relative to the third, likely destabilizing
intersubunit interactions in the context of an intact channel. Chloride anion
binding may represent one of the ways RyR2 uses to regulate channel opening.
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Arrhythmogenic Mechanisms in Catecholaminergic Polymorphic
Ventricular Tachycardia Linked to RyR2 Loss-of-Function Mutation
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To date, classical mechanisms of arrhythmogenesis in CPVT require sponta-
neous Ca2þ release via hyperactive RyR2 channels affected by gain-of-
function mutation. Here, we report novel arrhythmia mechanisms in a
CPVT-linked RyR2-A4860G mutation that depresses channel activity. Murine
RyR2-A4860G cDNA was expressed in CHO cells to the same level than wild-
type (WT), but recombinant RyR2-A4860G protein displayed dramatically
reduced channel activity by [3H]ryanodine binding assay and direct single
channel activity recording. Mice heterozygous for RyR2-A4860G mutation
(RyR2-A4860Gþ/-) exhibited basal bradycardia without cardiac structural
alterations; no homozygotes were detected at birth, indicating the mutation is
phenotypically too strong to be harbored in two alleles. Anesthetized RyR2-
A4860Gþ/- mice injected with arrhythmogenic cocktail (120mg/kg caffeine,
2mg/kg epinephrine) displayed ECG alterations of QRT alternans, premature
ventricular complexes and bidirectional ventricular tachycardia, while ECGs
of WT mice remained uneventful. Simultaneous recording of action potentials
(APs) and [Ca2þ]i transients in isoproterenol-stimulated RyR2-A4860G
þ/-ventricular myocytes showed prolonged APs and interspaced bursts of altered
Ca2þ release consisting of normal peak followed by a second, prolonged phase
of release. Remarkably, early afterdepolarizations (EADs) were observed only
during the prolonged phase of Ca2þ release, and were abolished by NCX inhib-
itor CB-DMB or intracellular Ca2þ chelator EGTA. SR Ca2þ load was higher in
RyR2-A4860Gþ/- cells before EADs but decreased to levels comparable to WT
after EADs. Simultaneous recording of ICa,L and [Ca
2þ]i transients showed
decreased transient amplitude and prolonged Ca2þ-dependent-inactivation of
ICa,L in RyR2-A4860G
þ/- cells. In conclusion, RyR2-A4860G loss-of-function
mutation decreases Ca2þ release amplitude and impairs ICa,L inactivation, both
of which gradually overload SR. The resultant SR overload then causes bursts
of prolonged Ca2þ release, activating electrogenic NCX activity during
APs and triggering EADs. The RyR2-A4860G mutation reveals novel path-
ways by which RyR2 channels engage membrane currents to produce
life-threatening arrhythmias.
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Preventing RyR2-S2808 and RyR2-S2814 Phosphorylation does not Alter
the b-Adrenergic Response of Mouse Hearts
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We previously showed that ablation of the cardiac Ca2þ release channel/
ryanodine receptor (RyR2) phosphorylation at Ser2808 (RyR2-S2808A) has
no functional impact on cardiac performance and/or heart failure progression.
In this study, we investigated whether this lack of effect may be due to compen-
satory mechanisms involving altered phosphorylation of the nearby Ser2814
CaMKII phospho-site. We generated a new mouse model where Ser2808 and
Ser2814 were genetically replaced by Alanine (RyR2-S2808A/S2814A). Anes-
thetized RyR2-S2808A/S2814A mice have normal ejection fraction at baseline
compared to wild type (WT) mice (55.152.6% vs. 55.952.4%, respectively,
n=7/group) but exhibit ~20% increase in heart rate (553533 vs. 460528
bpm, p<0.05, n=8/group). Langendorff-perfused hearts from both, RyR2-
S2808A/S2814A and WT mice displayed an equally robust increase in the
amplitude of isoprenaline (200nM)-stimulated LV contractions (60% and
63% above control in mutant and WT hearts, respectively, n=10/group,
p=0.7). In agreement with the whole-heart results, isoproterenol (100nM)-stim-
ulated RyR2-S2808A/S2814A myocytes displayed a comparable increase in
Ca2þ transient amplitude and sarcoplasmic reticulum (SR) Ca2þ content than
WT cardiomyocytes. Nevertheless, ablation of the S2808/S2814 phospho-
sites significantly decreased RyR2 refractoriness measured by a 2-pulse proto-
col (14257 vs. 19456 ms in the S2808A/S2814A and WT, respectively, n=7,
p<0.01). This effect was associated with a ~27% increase in SR Ca2þ leak
(3.2250.2 vs. 2.5350.2 DF/F0.100mm
1.s1 in the RyR2-S2808A/S2814A
and WT myocytes, respectively, n=17/group, p<0.05) causing earlier, faster
and more frequent spontaneous Ca2þ waves. Interestingly, 60% of RyR2-
S2808A/S2814A and 40% of the WT Langendorff-perfused hearts (n=10
each) exhibited arrhythmias upon isoprenaline stimulation. In conclusion, our
data show that inhibition of S2808 and S2814 phosphorylation leaves intact
the b-adrenergic response of the heart but accelerates RyR2 refractoriness,
increasing SR Ca2þ leak and promoting arrhythmic events.
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Suppressed RyR2 Function Represents a Common Cause of Idiopathic
Ventricular Fibrillation and Sudden Cardiac Death
Xiaowei Zhong1, Yijun Tang1, RuiwuWang1, Vern Hsen Tan2, Yingjie Liu1,
Lin Zhang1, Carlo Napolitano3, Silvia Priori3, SuiRong Wayne Chen1.
1University of Calgary, Calgary, AB, Canada, 2Foothills Hospital, University
of Calgary, Calgary, AB, Canada, 3University of Pavia, Pavia, Italy.
Cardiac Ryanodine Receptor (RyR2) is the major intracellular calcium release
channel located in the sarcoplasmic reticulum. A large number of mutations in
RyR2 have been linked to inherited cardiac arrhythmias (CPVT, catecholamin-
ergic polymorphic ventricular tachycardia and IVF, idiopathic ventricular
fibrillation) and sudden cardiac death. We previously demonstrated that in
contrast to CPVT RyR2mutations, the IVF RyR2mutation A4860G suppresses
RyR2 function. However, A4860G represents the only IVF RyR2 mutation that
has been functionally characterized to date. To determine how common
suppression-of-function RyR2 mutations are, we systematically characterized
27 RyR2 mutations that are associated with IVF or sudden cardiac death.
Each of these mutations was generated by site-directed mutagenesis and
expressed in HEK293 cells. Ca release assays revealed that 7 of these mutations
suppress or abolish caffeine-induced Ca release. Single cell Ca imaging studies
also indicated that these suppression- or loss-of-function RyR2 mutations
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in HEK293 cells. In addition, single channel analysis showed that these muta-
tions significantly reduce the response of the channel to activation by cytosolic
and luminal Ca. These observations demonstrate, for the first time, that sup-
pressed or loss of RyR2 function may be a common mechanism underlying
idiopathic ventricular fibrillation, which is opposite to the gain-of-function
RyR2 mutations associated with CPVT. Thus, understanding the exact molec-
ular defects of disease-causing RyR2 mutations will help to develop novel
approaches to the diagnosis and personalized treatment of these lethal cardiac
arrhythmias (Supported by CFI, CIHR, AIHS, and LCIA).
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Suppression of Spontaneous CA2D Release by Cardioprotective Drugs
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Spontaneous sarcoplasmic reticulum (SR) Ca2þ release in the form of Ca2þ
waves occurs in cardiac cells under conditions of SR Ca2þ overload. This
store-overload induced Ca2þ release (SOICR) is a well-known cause of delayed
afterdepolarization and triggered arrhythmias. Hence, inhibiting SOICR may
represent a promising therapeutic strategy for Ca2þ-triggered arrhythmias.
Indeed, we have recently shown that carvedilol, one of the most effective
beta-blockers for preventing ventricular tachyarrhythmias and sudden death
in heart failure, possesses a novel anti-SOICR activity. To identify more
SOICR inhibitors, we searched the DrugBank database (http://www.
drugbank.ca) for chemicals with structures similar to carvedilol. We selected
a number of hit compounds and assessed their impact on SOICR in HEK293
cells expressing a SOICR-promoting cardiac ryanodine receptor (RyR2) muta-
tion (R4496C). We found that curcumin and resveratrol (natural phenols) and
bevantolol (a beta blocker and a Ca2þ channel blocker) suppress SOICR in
HEK293 cells with IC50s of 6.750.3, 48.453.6, 64.7511.3mM, respectively.
On the other hand, gliclazide, diphenhydramine, crocin, dexrazoxane, and
trazodone displayed little or no SOICR inhibition. We also tested several other
known cardioprotective drugs. We found that docosahexaenoic acid (DHA),
eicosapentaenoic (EPA), arachidonic acid (AA), anandamide, and a novel
derivative of anandamide (CS-X-95) inhibit SOICR in HEK293 cells with
IC50s of 11.254.2, 5.150.5, 5.550.9, 14.755.1, and 11.550.7 mM, respec-
tively, whereas ranolazine and S107 have no significant impact on SOICR.
These observations indicate that many cardioprotective drugs exhibit
anti-SOICR activity, and that SOICR inhibition may contribute, in part, to their
cardioprotective effect. (Supported by NIH)
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Skeletal muscle ryanodine receptor (RyR1) is a Ca2þ release channel in the
sarcoplasmic reticulum membrane and plays a key role in excitation-
contraction coupling. Obtaining high-resolution 3D structure of RyR1 is a
formidable challenge due to its enormous size (~2.3 MDa), dynamic nature
and location in the lipid membrane in native state. Detergents are traditionally
used to make membrane proteins water soluble and suitable for single-particle
cryo-EM. However, detergents tend to destabilize and inactivate membrane
proteins. In addition, the presence of detergent in the protein sample reduces
surface tension of water making it difficult to control the ice thickness and dis-
tribution of channel particles in cryospecimen, and leads to low-contrast in
cryo-images. To overcome these difficulties we used amphipathic polymer, am-
phipol 8-35 (APol8-35), to substitute for detergent in RyR1 preparations. We
tested functionality of RyR1/APol8-35 in a [3H]ryanodine binding assay, which
yielded Kd and Bmax values similar to those of the purified RyR1 in the presence
of CHAPS, indicating that the high-affinity binding site for ryanodine is re-
tained in RyR1/APol8-35. The use of Apol8-35 allowed us to reproducibly
obtain ice-embedded specimens of RyR1 for cryo-EM analysis and resulted
in improved ice thickness with channel particles uniformly distributed across
the holes in the grids. The protein contrast of ice-embedded RyR1/APol8-35
is substantially higher than in detergent preparations using a traditional CCDdetector. Furthermore, low-dose images of vitrified RyR1/APol8-35 have
been collected on the DE-12 back-thinned DDD camera using JEM3200FSC
electron cryomicrosope operated at 300 keV at liquid nitrogen temperature.
Preliminary analysis of these cryo-EM images demonstrates image
signals that extend beyond ~6A˚. Optimal conditions for both sample
vitrification and data acquisition were reached in order to achieve a higher res-
olution RyR1 structure. Supported by NIH (R21AR063255, R01GM072804,
R01GM080139, P41GM103832) and AHA (12GRNT10510002).
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A functional hallmark of inositol 1,4,5-trisphosphate receptors (IP3Rs), the
main Ca2þ release channels in the endoplasmic reticulum of virtually all
eukaryotic cells, is the coupled interplay between the binding of primary
ligands, IP3 and Ca
2þ, and channel gating. IP3Rs are exceptionally large
integral membrane proteins, comprising four subunits of over 300 kDa each.
A central mechanistic question of IP3R function is how IP3 binding in the
N-terminal sequence of the channel protein is communicated to the ion-
conduction pore, which is formed close to the C-terminus. Using single-
particle cryo-EM, we have performed structural analysis of purified tetrameric
IP3R1 vitrified in the presence of micromolar Ca
2þ and saturating concentra-
tion of adenophostin A (AdA), a structural mimetic of IP3, that is a high-
affinity, full agonist of IP3Rs. Cryo-EM images of IP3R1 were recorded on a
Gatan 4k x 4k CCD camera in the JEM2010F cryomicroscope operated at
low-dose conditions. Using EMAN2, ~40,000 particle images were merged
to generate a preliminary 3D map of ligand-bound IP3R1 at ~15 A˚ resolution.
A comparison with our recent structure of IP3R1, determined without the addi-
tion of any channel ligands (Ludtke et al., 2010: Structure 19, 1192-99), reveals
structural rearrangements in the cytoplasmic domains of the ligand-bound
IP3R1 channel. Furthermore, we have performed docking studies of available
crystal structures of the ligand-binding domains into reconstructed cryo-EM
density maps of the entire IP3R1. All together our studies suggest that AdA/
Ca2þ binding induces conformational changes in the quaternary structure of
tetrameric IP3R1 that might underlie the long-range allosteric mechanism
of agonist-mediated activation of the ion-conducting pore of IP3R. Supported
by grants from NIH (R21AR063255, R01GM072804, R01GM080139,
P41GM103832) and by AHA (12GRNT10510002).
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We studied the synchronous function (coupled gating) of arrays of striated
muscle ryanodine receptors (RyRs) reconstituted into planar bilayers. We think
that understanding coupled gating would help explain local Ca2þ sparks and
global Ca2þ transients which arise from the simultaneous activation of groups
of RyRs in the sarcoplasmic reticulum. We have previously found that coupled
gating of multiple cardiac or skeletal RyRs requires luminal Ca2þ as current
carrier. In principle, this would suggest that Ca2þ flowing from the open
pore of a RyR, could activate neighboring channels (local CICR). However,
further analysis showed that coupled events are insensitive to changes in the
magnitude of lumen-to-cytosol Ca2þ flux. This is not compatible with the
idea of individual channels modulated by local CICR. As an alternative, we
tested the involvement of physical RyR-RyR interactions in the process of
coupled gating. We found that coupled gating of RyRs reconstituted in planar
bilayers is not significantly affected by agents that disrupt cytoskeletal
networks, FKBPs and/or kinases/phosphatases. However, the polycationic
amine spermine interfered with coupled RyR gating (suggesting a role for
electrostatic interactions). Additionally ryanodol, known to lock open channels
in a sub-conductance state, also affected coupled RyRs. Nevertheless, event
termination (synchronous channel closures) occurred even during ryanodol
substates. This was unexpected because single channels do not transition
from the ryanodol/ryanodine substate to the closed state. Overall, our results
suggest that modulation of coupled RyRs is different from that expected for
individual channels interacting by local CICR. We think that luminal Ca2þ pro-
motes conformational changes in RyRs allowing for cytosolic RyR-RyR
